WW GRAINGER INC
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
There have been no material changes from the risk factors previously disclosed in Part 1, Item 1A: Risk Factors in the Company's 2023 Form 10-K.
Issuer Purchases of Equity Securities – Third Quarter 2024
| Period | Total Number of Shares Purchased (A) | Average Price Paid per Share (B) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (C) | Maximum Number ofShares That May Yet be Purchased Under thePlans or Programs |
|---|---|---|---|---|
| Jul. 1 – Jul. 31 | 69,119 | $934.96 | 69,119 | 4,746,710 |
| Aug. 1 – Aug. 31 | 106,780 | $961.49 | 106,780 | 4,639,930 |
| Sep. 1 – Sep. 30 | 57,710 | $970.53 | 57,710 | 4,582,220 |
| Total | 233,609 | 233,609 |
A. There were no shares withheld to satisfy tax withholding obligations.
B. Average price paid per share excludes excise tax and commissions of $0.02 per share paid.
C. Priorto April 28, 2024, purchases were made pursuant to a share repurchase program approved by Grainger's Board of Directors and announced on April 28, 2021 (2021 Program). On April 24, 2024, Grainger's Board of Directors authorized a program for the Company to repurchase an aggregate amount of up to five million shares in the open market, through privately negotiated transactions and block transactions, pursuant to a trading plan or otherwise (2024 Program) with no expiration date. In authorizing the 2024 Program, the Board of Directors terminated the 2021 Program.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.